Comparison of 3 randomized clinical trials of frontline therapies for malignant pleural mesothelioma

T Meirson, F Pentimalli, F Cerza, G Baglio… - JAMA Network …, 2022 - jamanetwork.com
Importance Some recently proposed frontline therapies for malignant pleural mesothelioma
(MPM) are very costly, yet their impact on quality of life and overall survival of these patients …

Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma

T Meirson, F Pentimalli, F Cerza… - Faculty …, 2022 - scholarshare.temple.edu
Importance: Some recently proposed frontline therapies for malignant pleural mesothelioma
(MPM) are very costly, yet their impact on quality of life and overall survival of these patients …

[引用][C] Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma

T Meirson, F Pentimalli, F Cerza, G Baglio… - JAMA Network …, 2022 - cir.nii.ac.jp
Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural
Mesothelioma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …

[PDF][PDF] Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma

T Meirson, F Pentimalli, F Cerza, G Baglio, SG Gray… - core.ac.uk
IMPORTANCE Some recently proposed frontline therapies for malignant pleural
mesothelioma (MPM) are very costly, yet their impact on quality of life and overall survival of …

Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma.

T Meirson, F Pentimalli, F Cerza, G Baglio… - JAMA Network …, 2022 - europepmc.org
Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural
Mesothelioma. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …

[HTML][HTML] Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma

T Meirson, F Pentimalli, F Cerza, G Baglio… - JAMA Network …, 2022 - ncbi.nlm.nih.gov
Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural
Mesothelioma - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma

T Meirson, F Pentimalli, F Cerza… - JAMA network …, 2022 - pubmed.ncbi.nlm.nih.gov
Importance Some recently proposed frontline therapies for malignant pleural mesothelioma
(MPM) are very costly, yet their impact on quality of life and overall survival of these patients …

[PDF][PDF] Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma

T Meirson, F Pentimalli, F Cerza, G Baglio, SG Gray… - sanitainformazione.it
IMPORTANCE Some recently proposed frontline therapies for malignant pleural
mesothelioma (MPM) are very costly, yet their impact on quality of life and overall survival of …

Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma.

T Meirson, F Pentimalli, F Cerza, G Baglio… - JAMA Network …, 2022 - search.ebscohost.com
Abstract Key Points: Question: Are frontline therapies recommended for malignant pleural
mesothelioma (MPM) associated with patient benefits? Findings: In this comparative …

Comparison of 3 randomized clinical trials of frontline therapies for malignant pleural mesothelioma

T Meirson, F Pentimalli, F Cerza… - JAMA …, 2022 - salford-repository.worktribe.com
Importance: Some recently proposed frontline therapies for malignant pleural mesothelioma
(MPM) are very costly, yet their impact on quality of life and overall survival of these patients …